SAN RAMON, CA, November 5, 2025 — Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering innovations in fetal monitoring through advanced biophotonics and machine learning, today announced the initiation of an Investigational Device Exemption (IDE) Pilot Study at Louisiana State University Health Shreveport (LSUHS).
